Yong Hyo Kim

Title: Innovations of Yong Hyo Kim in Angiogenesis Inhibition

Introduction

Yong Hyo Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis inhibition. His work focuses on developing effective treatments for disorders associated with abnormal blood vessel growth.

Latest Patents

Yong Hyo Kim holds 1 patent for his invention titled "Pharmaceutical compositions for inhibiting angiogenesis comprising plant-derived natural compound." This innovative pharmaceutical composition utilizes a plant-derived natural compound that effectively prevents or treats diseases related to angiogenesis. The active ingredient in this composition suppresses VEGF-induced angiogenic responses without causing cytotoxicity at low concentrations. This approach enhances the safety profile of the drug by inhibiting the expression of anti-angiogenic factors.

Career Highlights

Yong Hyo Kim is affiliated with Yonsei University, where he conducts research and develops his innovative pharmaceutical solutions. His academic background and research experience have positioned him as a key figure in the field of pharmaceutical sciences.

Collaborations

Yong Hyo Kim collaborates with Ho Jeong Kwon, contributing to advancements in their shared research interests. Their partnership enhances the potential for innovative discoveries in the pharmaceutical domain.

Conclusion

Yong Hyo Kim's work in developing pharmaceutical compositions for inhibiting angiogenesis showcases his commitment to advancing medical science. His innovative approach promises to improve treatment options for various diseases associated with angiogenesis.